Reduced Claudin-3 Expression Is Linked to Unfavorable Tumor Features and Poor Prognosis in Non-Small Cell Lung Cancer
Lung Cancer: Targets and Therapy · 2026-01 · Volume 17 · 1-10
DOI: 10.2147/lctt.s530791 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lung Cancer: Targets and Therapy, 2026-01. Verfasst von Nina Schraps und 14 weiteren Autor:innen. Beteiligte Einrichtung: General, Visceral and Thoracic Surgery Department and Clinic, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
Claudin 3 (CLDN3) is a transmembrane protein which forms tight junctions (TJs) together with other claudins, occludin, and junctional adhesion molecules. Because of its membranous localization CLDN3 is a potential therapeutic target. Altered CLDN3 has been proposed as a prognostic feature in lung cancer and other tumors. Material and Methods: To better understand the prevalence of expression and its impact on the prognosis of different lung cancer subtypes, we investigated CLDN3 expression by immunohistochemistry in a set of tissue microarrays containing 858 resected lung cancers.
Results
CLDN3 positivity was markedly more frequent and more intense in pulmonary adenocarcinoma (AC, 95.9% positive) than in squamous cell carcinoma (SCC, 53.3%; p
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- General, Visceral and Thoracic Surgery Department and Clinic, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Department of Thoracic Oncology, Airway Research Center North, German Center for Lung Research, LungenClinic, Grosshansdorf, Germany.
- Department of Thoracic Surgery, Airway Research Center North, German Center for Lung Research, LungenClinic, Grosshansdorf, Germany.
- Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Institute of Pathology, Clinical Center Osnabrueck, Osnabrueck, Germany.
ORCID-Profile: Nina Schraps, Martina Kluth, Ronald Simon
Zitieren
APA
Schraps, N., Reck, M., Hantzsch-Kuhn, B., Olchers, T., Ellebrecht, D. B., Möller, K., Fraune, C., Lennartz, M., Lutz, F., Kluth, M., Makrypidi-Fraune, G., Simon, R., Sauter, G., Steurer, S., & Von Weihe, S. (2026). Reduced Claudin-3 Expression Is Linked to Unfavorable Tumor Features and Poor Prognosis in Non-Small Cell Lung Cancer. Lung Cancer: Targets and Therapy, Volume 17, 1-10. https://doi.org/10.2147/lctt.s530791
Vancouver
Schraps N, Reck M, Hantzsch-Kuhn B, Olchers T, Ellebrecht DB, Möller K, et al. Reduced Claudin-3 Expression Is Linked to Unfavorable Tumor Features and Poor Prognosis in Non-Small Cell Lung Cancer. Lung Cancer: Targets and Therapy. 2026;Volume 17:1-10. doi:10.2147/lctt.s530791
BibTeX
@article{Schraps2026,
author = {Schraps, Nina and Reck, Martin and Hantzsch-Kuhn, Birgit and Olchers, Till and Ellebrecht, David Benjamin and Möller, Katharina and Fraune, Christoph and Lennartz, Maximilian and Lutz, Florian and Kluth, Martina and Makrypidi-Fraune, Georgia and Simon, Ronald and Sauter, Guido and Steurer, Stefan and Von Weihe, Sönke},
title = {Reduced Claudin-3 Expression Is Linked to Unfavorable Tumor Features and Poor Prognosis in Non-Small Cell Lung Cancer},
journal = {Lung Cancer: Targets and Therapy},
year = {2026},
volume = {Volume 17},
pages = {1--10},
doi = {10.2147/lctt.s530791}
}
EUVIMED